SCHEMBL27498940

SCHEMBL27498940

CC(=O)SCCn1cnc2c(N)ncnc21

nearest known ligand 0.61

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 8/20 0.61
▸ ADORA1 P30542 4/20 0.61
▸ ADORA2B P29275 1/20 0.61
▸ ADCY5 O95622 4/20 0.56
▸ PI4KA P42356 2/20 0.56
▸ PI4K2B Q8TCG2 2/20 0.56
▸ PI4K2A Q9BTU6 2/20 0.56
▸ PI4KB Q9UBF8 2/20 0.56
▸ AHCY P23526 3/20 0.56
▸ ALDH1A1 P00352 1/20 0.53
▸ FGFR1 P11362 1/20 0.52
▸ SLC22A6 Q4U2R8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27499558 0.91 ADORA2A (0.61) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL13882135 0.82 ADORA2A (0.66) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL13870051 0.81 ADORA2A (0.69) ADORA2AADORA1ADORA2BPI4KAPI4K2B
SCHEMBL11222112 0.79 ADORA2A (0.80) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL27713663 0.79 EGFR (0.64) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL5038900 0.78 SLC22A6 (0.62) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL12922452 0.77 ALDH1A1 (0.62) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL11986908 0.77 ALDH1A1 (0.62) ADORA2AADORA1ADORA2BADCY5PI4KA
Methylglyoxal SCHEMBL6013418 0.77 ADORA2A (0.76) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL11986907 0.77 ADORA2A (0.59) ADORA2AADORA1ADORA2BADCY5PI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1234718-C New macrolides with antibacterial activity BASILEA PHARMACEUTICA AG (CH) 2006-01-04 — — CN disclosed
CN-1464880-A New macrolides with antibacterial activity BASILEA PHARMACEUTICA AG (CH) 2003-12-31 — — CN disclosed
Send feedback